---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-240642"
form_type: "8-K"
ticker: "LFST"
cik: "0001845257"
company_name: "LifeStance Health Group, Inc."
filed_at: "2022-09-08T23:59:59+00:00"
generated_at: "2026-06-23T13:10:22.285458+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# LifeStance appoints Ken Burdick as CEO/Chairman; founding CEO Michael Lester retires

## Summary
- Ken Burdick appointed CEO and Chairman effective Sept 7, 2022; succeeds Michael Lester who retires as officer and director.
- Danish Qureshi named President in addition to his role as COO.
- Lester's Alert5 Consulting LLC receives $50,933.33/month consulting fee through Sept 7, 2023.
- Burdick gets $700,000 base salary, target bonus 100% of base, and option for 9,404,539 shares with time/performance vesting.
- Qureshi receives option for 2,821,362 shares with one-third time-based and two-thirds performance-based vesting.

## SEC filing metadata
- accession: 0001193125-22-240642
- form_type: 8-K
- ticker: LFST
- cik: 0001845257
- company_name: LifeStance Health Group, Inc.
- filed_at: 2022-09-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845257/000119312522240642/0001193125-22-240642-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845257/000119312522240642/d320877d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-240642
- JSON: https://secwatch.observer/filing/0001193125-22-240642.json
- Plain text: https://secwatch.observer/filing/0001193125-22-240642.txt

## Key facts
- Executive change
  Michael Lester departed as President, Chief Executive Officer and Chairman at LifeStance Health Group, Inc..
  - Action: retiring
  - Role: President, Chief Executive Officer and Chairman
  source text: Mr. Burdick succeeds Michael Lester, who has served as the Company’s President and Chief Executive Officer and Chairman since 2017 and who is retiring from his officer and director roles effective upon Mr. Burdick’s appointment on the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1845257/000119312522240642/0001193125-22-240642-index.htm
- Executive change
  Danish Qureshi was appointed as President at LifeStance Health Group, Inc..
  - Action: appointed
  - Role: President
  source text: Danish Qureshi, the Company’s Chief Operating Officer, was appointed as the Company’s President, in addition to his role as Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1845257/000119312522240642/0001193125-22-240642-index.htm
- Executive change
  Kenneth Burdick was appointed as Chief Executive Officer and Chairman of the Board at LifeStance Health Group, Inc..
  - Action: appointed
  - Role: Chief Executive Officer and Chairman of the Board
  source text: appointed Kenneth Burdick as the Company’s new Chief Executive Officer and Chairman of the Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1845257/000119312522240642/0001193125-22-240642-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.